Promoting research partnerships to improve veterans’ health

NAVREF is proud to recognize Cohen Veterans Bioscience as our Champion Sponsor

DoD Psychological Health & Traumatic Brain Injury Research Program Funding Announcement

17 Jul 2019 8:22 AM | Hawk Tran (Administrator)

The FY19 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health and Traumatic Brain Injury Research Program (PHTBIRP) to support specific Defense Health Agency (DHA) J9 Research and Development Directorate program areas, including Joint Program Committee-5/Military Operational Medicine Research Program (JPC-5/MOMRP).  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

The FY19 PHTBIRP Program Announcement and General Application Instructions for the following award mechanism are posted on the website.

Prevention Research to Reduce Sexual Assault and/or Understand Adjustment Disorders (PSAAD) – Letter of Intent Due September 19, 2019

Investigators at all academic levels are eligible to be names as a Principal Investigator on the application.

  • The PSAAD IIFRA is intended to support research focused on (1) development or adaptation of prevention efforts to reduce the occurrence of sexual assault and/or harassment and/or (2) understanding the diagnosis, assessment, and screening of adjustment disorders as a consequence of sexual assault and/or stressors that precipitate adjustment disorders.
  • All applications must address at least one of the PSAAD IIFRA Focus Areas and be of clear scientific merit with direct relevance to military and public health.
  • Research involving human subjects is permitted; however, this award may not be used to conduct clinical trials.
  • Preclinical research using animals is not permitted.
  • This funding opportunity is not focused on Veterans.
  • Submission of a Letter of Intent is required.
  • Maximum funding of $750K for direct costs (includes direct and indirect costs).
  • Maximum period of performance is 3 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the website.  The application package containing the required forms for each award mechanism will also be found on  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at  For more information about the PHTBIRP or other CDMRP-administered and supported programs, please visit the CDMRP website (

Point of Contact:

CDMRP Help Desk


1717 K ST NW Suite 900

Washington, DC 20006

P: 301-656-5005  |

Powered by Wild Apricot Membership Software